TAVR (TAVI)
This session features leading surgeons discussing various aspects of transcatheter aortic valve implantation (TAVI) planning at the Transcatheter Heart Valves Greece (THVGreece) 2026 conference. Please note that all presentations are delivered in Greek. The first...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Dr. Aamir Amin, a cardiothoracic surgery resident at Manchester University NHS Foundation Trust, UK, about humanoid robots and artificial...
This session features leading surgeons discussing the tricuspid valve at the Transcatheter Heart Valves Greece (THVGreece) 2026 conference. Moderators Vassilis Voudris, Director of the Cardiology/Interventional Cardiology Division, Onassis Cardiac Surgery...
In this episode of The Atrium, host Dr. Alice Copperwheat speaks with Dr. Filip Casselman, Staff Surgeon and Co-Director of the Cardiovascular Center at OLV Clinic (AZORG), Aalst, Belgium, about...
This video completes a day of excellent presentations by leading surgeons exploring advanced minimally invasive techniques including congenital ventricular septal defect (VSD) surgery, endoscopic transcatheter aortic valve replacement (TAVR) explantation,...
Data from the PARTNER trials were assessed regarding post-procedural prosthetic valve endocarditis (PVE) after transcatheter aortic valve replacement and surgical aortic valve replacement. The timing and rates of PVE were...
Reporting of postmarket outcomes for the Sapien 3 and Mitraclip devices frequently misclassified patient deaths as device malfunction or other outcomes. Misclassification for Sapien 3 involved 17.5% of patient deaths,...
Using an approach that minimizes valve depth relative to the membranous septum, the authors reduced the need for permanent pacemaker placement to a reliable and predictable 3% compared to the...
The FDA-approved use of TAVR has now expanded to low-risk patients with severe aortic stenosis. This includes both Edwards Lifesciences’ Sapien 3 and Sapien 3 Ultra as well as Medtronic’s...
Objectives Transcatheter aortic valve replacement (TAVR) has become the standard of care for high-risk patients and is growing in popularity for lower risk patients. The authors report a case of...
This retrospective study by Sedeek et al aimed to compare the outcomes of patients undergoing transcatheter aortic valve replacement (TAVR) valve-in-valve (n=90) versus surgical replacement (SAVR) (n=260) of failing stented...
Patient Care and General Interest The American Heart Association published a statement advocating for a holistic care approach for patients with Fontan circulation, noting that these patients are living longer...
Transcatheter aortic valve replacement (TAVR) is expanding to younger patients, but the feasibility of TAVR in failing transcatheter aortic valves (TAV) remains unknown. Dr Tang and colleagues demonstrate in a...


